NCT05378984

Brief Summary

This experimental randomized, double-blind, and controlled study included fifteen young, healthy, and pain-free men and 15 age-matched women. It lasted for three visits with at least one-week washout. Pain was experimentally induced, twice at each visit, with intramuscular injections of 0.2 mL hypertonic saline (5%), before and after intake of one of the different chocolate-types; white (30% cocoa-content), milk (34% cocoa-content), dark (70% cocoa-content). Pain duration, pain area, peak pain, and pressure pain threshold were assessed every fifth minute after each injection, between the time-points 5 to 30 min. Prior to inclusion, all participants underwent an examination in a dental chair. This included a clinical examination of the orofacial region according to the Diagnostic Criteria for temporomandibular disorders (DC/TMD) by a blinded examiner. Participants were also examined regarding their psychosocial status prior to inclusion, this included depression, somatization, anxiety, pain catastrophizing and stress.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 10, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 18, 2022

Completed
Last Updated

May 24, 2022

Status Verified

May 1, 2022

Enrollment Period

10 months

First QC Date

May 10, 2022

Last Update Submit

May 17, 2022

Conditions

Keywords

MyalgiaExperimental painHumanTemporomandibular disordersCocoa

Outcome Measures

Primary Outcomes (4)

  • Change in pain intensity by intake of chocolate

    Pain intensity will be assssed using a 0-100 visual analoge scale (0-no pain; 100-worst pain ever experienced)

    5 min after injection of hypertonic saline

  • Change in peak pain intensity before and after intake of chocolate

    Peak pain intensity will be asessed from the 0-100 visual analoge scale (0-no pain; 100-worst pain ever experienced)

    5 min after injection of hypertonic saline

  • Change in pain duration by intake of chocolate

    Pain duration is assessed in seconds.

    Pain duration up to 300 seconds after injection of hypertonic saline

  • Change in pain area by intake of chocolate

    Pain area will be marked on lateral charts of the head before and after intake of chocolate and measured in au.

    Pain area is marked 5 min after injection of hypertonic saline

Secondary Outcomes (1)

  • Change in pressure pain threshold by intake of chocolate

    Pressure pain thresholds are assessed 5 min after injection of hypertonic saline

Study Arms (3)

Dark Chocolate

ACTIVE COMPARATOR
Other: before - hypertonic saline 5%Other: after - hypertonic saline 5%

Milk Chocolate

ACTIVE COMPARATOR
Other: before - hypertonic saline 5%Other: after - hypertonic saline 5%

White Chocolate

ACTIVE COMPARATOR
Other: before - hypertonic saline 5%Other: after - hypertonic saline 5%

Interventions

pain was induced by intramuscular injections of hypertonic saline (5%)

Dark ChocolateMilk ChocolateWhite Chocolate

pain was induced by intramuscular injections of hypertonic saline (5%)

Dark ChocolateMilk ChocolateWhite Chocolate

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • good general health
  • age between 18-40 years

You may not qualify if:

  • any pain-related diagnosis of TMD or of the orofacial region
  • any headaches
  • a diagnosis of systemic muscular or joint diseases (fibromyalgia or rheumatoid arthritis)
  • whiplash-associated disorders
  • neurological disorders
  • psychiatric disorders
  • any allergy to the substances used

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet, Department of Dental Medicine

Huddinge, 141 04, Sweden

Location

Related Publications (1)

  • Hajati A, Brondani M, Angerstig L, Klein V, Liljeblad L, Al-Moraissi EA, Louca Jounger S, Brondani B, Christidis N. Chocolate intake and muscle pain sensation: A randomized experimental study. PLoS One. 2023 May 24;18(5):e0284769. doi: 10.1371/journal.pone.0284769. eCollection 2023.

MeSH Terms

Conditions

MyalgiaTemporomandibular Joint Disorders

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesMusculoskeletal PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCraniomandibular DisordersMandibular DiseasesJaw DiseasesJoint DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The chocolate given to the participant was of a different concentration of cocoa, distributed in a randomized and double-blinded order. The participants where given the chocolate with their eyes closed. A non-blinded examiner fed the chocolate to the participant at each clinical trial, while a blinded examiner did the assessments. The different types of chocolates were given at three different visits to all participants with at least one week of washout in between. To randomize the order in which the chocolates were given to each participant, an internet-based site was used (www.randomization.com; Seed 19525). The randomization was done in five blocks of six participants each, by a researcher who did not participate in the data collection
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor, senior lecturer, senior consultant

Study Record Dates

First Submitted

May 10, 2022

First Posted

May 18, 2022

Study Start

March 1, 2020

Primary Completion

December 20, 2020

Study Completion

December 20, 2020

Last Updated

May 24, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share

Data will be shared with other researchers upon request from any of the authors

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
After publication and up to 20 years after publication
Access Criteria
Data will be shared with other researchers upon request from any of the authors

Locations